Obermatt

Raia Drogasil

SAO:RADL3 · BRRADLACNOR0
Food & Staples RetailingX-Large

360

81
EV / EBIT44
Price / Owner Earnings25
Owner Earnings Yield37
Dividend Yield71
Price/Sales47
EV / Gross Profit46
Price/Book25
Return on Capital77
Cash Return on Capital44
Return on Equity70
EBIT Margin74
Gross Profitability64
Cash Conversion49
Accruals37
Owner Earnings Margin49
Sales growth25
Profit Growth82
Long-Term EPS Growth92
Owner Earnings Growth89
Reinvestment43
Price momentum83
Debt load27
Refinancing51
Debt Payback43
Liquidity30
Analyst ratings40
Opinion Changes37
Price Target Upside95
Market mood75
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Raia Drogasil generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryBrazil
IndustryFood & Staples Retailing
SizeX-Large
TypePublic Company
ExchangeBOVESPA
Employees6,366
ISINBRRADLACNOR0
Last UpdateApr 2, 2026
Themes
Health DiagnosticsChronic DiseasesLifestyleWellness and RecoveryFast-Moving Consumer GoodsVaccinesRetail

Description

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Business Segments The company’s business is organized into several key segments, each cont…

Analysis

Middle-of-the-road

Raia Drogasil S.A. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 42.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 16% a year, against analyst forecasts of 21%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is adequate. The company scores 14/20 on our value-creation score: strong value creator. Analysts lean positive.

Flags to be aware of: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
39
2023202420252026

All-time high

79

Dec 2025

All-time low

12

Oct 2025

Average rank

47

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
47
49
25
36
Price/Earnings
37
29
15
32
Price/Book
25
22
11
20
Dividend Yield
71
20
20
24
Value (overall)
45
9
7
9

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Raia Drogasil with its peers
Aspen Pharmacare
JNB:APN
22
CountrySouth Africa
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Companhia Brasileira de Distribuicao
SAO:PCAR3
4
CountryBrazil
IndustryFood & Staples Retailing
SizeMedium
Full Stock Analysis →
We Buy Cars
JNB:WBC
86
CountrySouth Africa
IndustrySpecialty Retail
SizeSmall
Full Stock Analysis →
C&A Modas
SAO:CEAB3
89
CountryBrazil
IndustrySpecialty Retail
SizeMedium
Full Stock Analysis →
Magazine Luiza
SAO:MGLU3
42
CountryBrazil
IndustryMultiline Retail
SizeLarge
Full Stock Analysis →
Sendas Distribuidora
SAO:ASAI3
53
CountryBrazil
IndustryFood & Staples Retailing
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →